Evoke Wealth’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-412
Closed -$73K 741
2022
Q3
$73K Hold
412
﹤0.01% 467
2022
Q2
$75K Hold
412
﹤0.01% 447
2022
Q1
$106K Hold
412
﹤0.01% 424
2021
Q4
$95K Hold
412
﹤0.01% 453
2021
Q3
$95K Hold
412
﹤0.01% 430
2021
Q2
$80K Hold
412
﹤0.01% 471
2021
Q1
$85K Sell
412
-186
-31% -$39.5K ﹤0.01% 396
2020
Q4
$112K Hold
598
0.01% 291
2020
Q3
$77K Buy
598
+256
+75% +$28.2K 0.01% 310
2020
Q2
$30K Sell
342
-304
-47% -$23.4K ﹤0.01% 415
2020
Q1
$38.9K Hold
646
0.01% 363
2019
Q4
$47.9K Hold
646
0.01% 423
2019
Q3
$39.4K Buy
+646
New +$42.5K ﹤0.01% 509

Other funds holding INSP

Evoke Wealth's INSP Position: Q4 2022 in Review

Evoke Wealth sold out of Inspire Medical Systems (INSP) in Q4 2022, closing a stake of 412 shares — an estimated $73K sold.

Evoke Wealth first reported a position in INSP in Q3 2019 and held it in 13 quarters. The position peaked at $112K in Q4 2020. 340 funds tracked by Wall St. Rank hold INSP as of Q4 2022.

  • Evoke Wealth reported no remaining Inspire Medical Systems position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 412 Inspire Medical Systems shares in Q4 2022, an estimated $73K.
  • Evoke Wealth first reported a position in Inspire Medical Systems in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Inspire Medical Systems position peaked at $112K in Q4 2020.
  • 340 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.